CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- 4 Shares withheld for taxes President, Research & Develop. gave up 1,760 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,734 shares (to pay taxes)
- 4 Open-market sale Director sold 27,000 shares at $7.50 ($202,554)
- 4 Open-market sale 10% owner sold 27,000 shares at $7.50 ($202,554)
- 4 Open-market sale Director sold 125,000 shares at an average $6.93 ($866,633)
- 4 Open-market sale 10% owner sold 125,000 shares at an average $6.93 ($866,633)
- 4/A Open-market buy Director bought 50,000 shares at an average $14.63 ($731,683)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Chief Financial Officer acquired 11,134 shares (option exercise)
- 4 Planned sale Chief Financial Officer sold 1,784 shares at $10.67 ($19,035)
- 4 Shares withheld for taxes CEO gave up 17,566 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 4,929 shares (to pay taxes)
- 4 Shares withheld for taxes President & COO gave up 5,144 shares (to pay taxes)
- 4 Shares withheld for taxes President, Research & Develop. gave up 6,138 shares (to pay taxes)
Page 3 of 13 · 242 filings